However, its function in vivo remains poorly understood
Your gut issues are not "just stress." Your chronic inflammation is not something you have to accept
Survodutide Research# Survodutide has two published Phase 2 trials: the obesity trial (Lancet Diabetes & Endocrinology, 2024) showing 18.7% weight loss at 46 weeks, and the MASH trial (NEJM, 2024) showing 62% MASH resolution
1 (download XLSX Statistical source data
Also worth noting: Many compounded medications (including some GLP-1 options like sublingual drops) are not FDA-approved in that form EllieMD connects you with licensed providers, which adds a layer of oversight, but its still important to ask questions, understand what youre taking, and listen to your body
Subsequent Pearson correlation analysis showed that most immune checkpoints were negatively associated with sermorelin, suggesting a potential immune-modulatory effect